U.S. Markets closed
  • S&P 500

    3,635.41
    +57.82 (+1.62%)
     
  • Dow 30

    30,046.24
    +454.97 (+1.54%)
     
  • Nasdaq

    12,036.79
    +156.15 (+1.31%)
     
  • Russell 2000

    1,853.53
    +35.23 (+1.94%)
     
  • Crude Oil

    44.77
    -0.14 (-0.31%)
     
  • Gold

    1,804.70
    +0.10 (+0.01%)
     
  • Silver

    23.29
    -0.01 (-0.04%)
     
  • EUR/USD

    1.1901
    +0.0004 (+0.0357%)
     
  • 10-Yr Bond

    0.8820
    +0.0250 (+2.92%)
     
  • Vix

    21.64
    -1.02 (-4.50%)
     
  • GBP/USD

    1.3362
    +0.0003 (+0.0254%)
     
  • USD/JPY

    104.5310
    +0.0510 (+0.0488%)
     
  • BTC-USD

    19,101.53
    -18.78 (-0.10%)
     
  • CMC Crypto 200

    379.74
    +9.99 (+2.70%)
     
  • FTSE 100

    6,432.17
    +98.33 (+1.55%)
     
  • Nikkei 225

    26,575.27
    +409.68 (+1.57%)
     

Regenxbio: 3Q Earnings Snapshot

·1 min read

ROCKVILLE, Md. (AP) _ Regenxbio Inc. (RGNX) on Wednesday reported third-quarter net income of $8.8 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Rockville, Maryland-based company said it had net income of 23 cents.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 89 cents per share.

The biotechnology company posted revenue of $98.9 million in the period.

Regenxbio shares have fallen 24% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $31.07, a decline of 16% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX